Review





Similar Products

nras g12d  (Jackson Laboratory)
86
Jackson Laboratory nras g12d
(A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and <t>Tet-On-ME/Nras</t> <t>G12D</t> models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.
Nras G12d, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nras g12d/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
nras g12d - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier
phage kras g12d vector  (Addgene inc)
86
Addgene inc phage kras g12d vector
(A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and <t>Tet-On-ME/Nras</t> <t>G12D</t> models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.
Phage Kras G12d Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phage kras g12d vector/product/Addgene inc
Average 86 stars, based on 1 article reviews
phage kras g12d vector - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier
kras g12d  (Cell Signaling Technology Inc)
86
Cell Signaling Technology Inc kras g12d
(A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and <t>Tet-On-ME/Nras</t> <t>G12D</t> models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.
Kras G12d, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kras g12d/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
kras g12d - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier
anti ras g12d  (Cell Signaling Technology Inc)
86
Cell Signaling Technology Inc anti ras g12d
(A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and <t>Tet-On-ME/Nras</t> <t>G12D</t> models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.
Anti Ras G12d, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ras g12d/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
anti ras g12d - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier
lentivirus plasmids expressing kras g12d  (Addgene inc)
86
Addgene inc lentivirus plasmids expressing kras g12d
(A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and <t>Tet-On-ME/Nras</t> <t>G12D</t> models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.
Lentivirus Plasmids Expressing Kras G12d, supplied by Addgene inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lentivirus plasmids expressing kras g12d/product/Addgene inc
Average 86 stars, based on 1 article reviews
lentivirus plasmids expressing kras g12d - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier
phage kras g12d  (Addgene inc)
86
Addgene inc phage kras g12d
(A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and <t>Tet-On-ME/Nras</t> <t>G12D</t> models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.
Phage Kras G12d, supplied by Addgene inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phage kras g12d/product/Addgene inc
Average 86 stars, based on 1 article reviews
phage kras g12d - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier

Image Search Results


(A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and Tet-On-ME/Nras G12D models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.

Journal: bioRxiv

Article Title: Fetal context conveys heritable protection against MLL-rearranged leukemia that depends on MLL3

doi: 10.1101/2025.03.11.642680

Figure Lengend Snippet: (A, B) Kaplan-Meier survival curves after E10.5 or P0 MLL::ENL induction using Tet-On-ME and Tet-On-ME/Nras G12D models. (C) Summary of experimental set-up for MLL::ENL induction and transplantation experiments. (D) Kaplan-Meier survival curves for recipient mice transplanted with 300,000 P0 liver cells or 500 LSK cells after MLL::ENL induction at E10.5 or P14. (E) Donor (CD45.2) leukocyte engraftment in surviving recipient mice at 8 months after transplantation. (F) Summary of experimental set-up for panels G and H, and for CITE-seq experiments in . (G) Kaplan-Meier survival curves and 16-week donor chimerism for recipient mice after MLL::ENL induction at E10.5 or P0 and transplantation at P28. (H) MLL::ENL transgene expression (counts per million; CPM) based on RNA-seq. n= 4 biological replicates per group, ***p<0.001 by one-way ANOVA with Tukey’s posthoc test. For all survival curves, group sizes and p-values are shown in the panels. p-values were calculated by the log rank test.

Article Snippet: Vav1-Cre (RRID:IMSR_JAX:008610), Rosa26 LSL-rtTA-IRES-mKate2 (RRID:IMSR_JAX:008610), Rosa26 LSL-tTA (RRID:IMSR_JAX:011008), Col1a1 TetO-H2B-GFP (RRID:IMSR_JAX:016836) and Nras G12D (RRID:IMSR_JAX:008304), were obtained from Jackson Laboratory.

Techniques: Transplantation Assay, Expressing, RNA Sequencing